Work

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours

Year: 2022

Type: review

Source: Nature Reviews Clinical Oncology

DOI: 10.1038/s41571-022-00704-3

Authors: Christian L. Flugel, Robbie G. Majzner, Giedre Krenciute, Gianpietro Dotti, Stanley R. Riddell, Dimitrios L. Wagner, Mohamed Abou-el-Enein

Institutions: University of Southern California, Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin, Stanford Medicine, Stanford Cancer Institute, Stanford University, St. Jude Children's Research Hospital, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, University of Washington, Fred Hutch Cancer Center, Humboldt-Universität zu Berlin, Freie Universität Berlin, Children's Hospital Los Angeles

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Assisi Foundation of Memphis, University of Southern California, National Institutes of Health, University of California, San Francisco, National Cancer Institute, National Institute of Neurological Disorders and Stroke

Awards: G3658079094, University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG), Improving genetically engineered T cells for medulloblastomas

OpenAlex ID: W4309889967

FWCI: 12.01

Cites: 167

Cited by: 571

Related to: 10